BioSpace News Archive

The HydraFacial™ Company announced today that they have partnered with Dr. Paul Nassif and NassifMD Dermaceuticals™ to launch Hydraglucan™ Intense Hydration Booster.

The Cellvizio® 100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries

EOS imaging, a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, announces the information relating to the number of voting rights and shares as at 31 December 2019.

Agilent Technologies Inc. (NYSE: A) today introduced a new product designed to address key challenges that laboratories encounter when preparing DNA sequencing libraries for their research

Responding to a frequently cited pain point for both orthopedic physicians and their patients, Breg, Inc.'s latest software release will improve transparency around the cost of durable medical equipment (DME) products like knee braces, shoulder slings, splints, boots and crutches at the time of dispensement.

Philanthropic and private sector support will help address fast-emerging response needs

Contact Lens Wearers Can Now Recycle Their Contact Lenses and Blister Packs

Applied BioMath (www.appliedbiomath.com), today announced Lucia Wille, PhD, Head of Biology at Applied BioMath will present, “Quantitative Systems Pharmacology Model of Tau Spreading in Alzheimer’s Disease to Enable Drug Development” at the Tau2020 Global Conference occurring February 12-13, 2020 in Washington, D.C.

Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada for Drax Exametazine® (Kit for the Preparation of Tc99m Exametazime for leukocyte labeling).

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced the closing of its previously announced public offering of 3,750,000 common shares pursuant to its existing shelf registration statement at a public offering price of $16.00 per share